Walking Tall app goes to bat for people with Parkinson’s disease
People with Parkinson’s disease can learn how to re-train their gait and improve their walking ability with the help…
Articles by Andrea Lobo
RaceTrac’s ‘Run for Research’ event on Sept. 16 to support MJFF
RaceTrac is set to revive its “Run for Research” 5K race, scheduled for Sept. 16 at Truist Park in…
Foundation invests $2.8M in 30 grants for innovative research
The Parkinson’s Foundation is investing $2.8 million in 30 research grants to help advance potential new therapies for…
Cannabinoid that might help in Parkinson’s entering Phase 2 trial
Gcanrx soon will open a Phase 2 clinical trial of a neuroprotective cannabinoid treatment that the company expects could…
Minor hallucinations may predict Parkinson’s cognitive decline: Study
The early appearance of minor hallucinations in people with Parkinson’s disease might be a predictor of faster cognitive decline,…
Cell therapy bemdaneprocel safe in advanced Parkinson’s: Phase 1 trial
Treatment with bemdaneprocel (BRT-DA01), BlueRock Therapeutics’s investigational cell-based therapy, was safe and well tolerated among patients with advanced-stage…
Parkinson’s Foundation expands specialized care network
The Parkinson’s Foundation has expanded its Global Care Network by adding four Centers of Excellence and four Comprehensive…
Potential gene therapy may help with GBA1-linked Parkinson’s
Freeline Therapeutics announced plans to leverage knowledge gained from its FLT201Â gene therapy program in Gaucher disease…
Buntanetap Phase 3 study to move forward after positive safety review
Following a positive safety review, Annovis Bio‘s Phase 3 clinical trial testing oral buntanetap for the treatment of early-stage…
New trial aims to advance research in diseases like Parkinson’s
Koneksa has partnered with Beacon Biosignals to launch a clinical trial focused on advancing research in neuroscience, including…